A carregar...

Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years

The mechanistic target of rapamycin (mTOR) is a central regulator in cell growth, activation, proliferation, and survival. Activation of the mTOR pathway underlies the pathogenesis of systemic lupus erythematosus (SLE). While mTOR activation and its therapeutic reversal were originally discovered in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Rheumatol Rep
Main Authors: Oaks, Zachary, Winans, Thomas, Huang, Nick, Banki, Katalin, Perl, Andras
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5314949/
https://ncbi.nlm.nih.gov/pubmed/27812954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11926-016-0622-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!